DJIA 18,053.71 23.50 0.13%
NASDAQ 4,806.86 33.39 0.70%
S&P 500 2,088.77 6.89 0.33%
market minute promo

141.46 1.13 (0.81%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

VRX $141.46 0.81%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $141.10
Previous Close $140.33
Daily Range $140.52 - $142.29
52-Week Range $106.00 - $153.10
Market Cap $47.5B
P/E Ratio 91.12
Dividend (Yield) $0.00 (0.0%)
Volume 617,160
Average Daily Volume 2,116,121
Current FY EPS $2.96





Valeant Pharmaceuticals (VRX) Description

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology. Website:

News & Commentary

Top Pharmaceutical Stocks to Buy for 2015

Three fast-growing pharmaceutical stocks that investors may want to consider owning in 2015.

Are There Any Winners Left In The Biotech Space?

Aerie: A Brilliant Future, Derisking In Progress, And The Making Of A Major Ophthalmic Pharmaceutica

Aerie: A Brilliant Future, Derisking In Progress, And The Making Of A Major Ophthalmic Pharmaceutical

Gilead/Ono Pharmaceutical Ink Deal for Blood Cancer Drug - Analyst Blog

Today's Momo Momentum Stock Is Valeant Pharmaceuticals International (VRX)

The Best Healthcare Stocks of 2014: Which Is Our Favorite for 2015?

In this week's Industry Focus, our analysts discuss their favorites of the successful 2014 healthcare large-cap stocks.

Emergent BioSolutions Buys EV-035 Series from Evolva - Analyst Blog

UCB's Kremers Urban Sale Deal Lapses, Divestiture Plan On - Analyst Blog

Cyclacel Falls on Poor Acute Myeloid Leukemia Drug Data - Analyst Blog

Insider Trading Alert - METR, VRX And EGBN Traded By Insiders

See More VRX News...

VRX's Top Competitors

VRX $141.46 (0.81%)
Current stock: VRX
JNJ $105.06 (0.45%)
Current stock: JNJ
NVS $94.10 (0.20%)
Current stock: NVS
RHHBY $34.23 (-0.16%)
Current stock: RHHBY